The fall 2017 issue of Bench to Bedside featured Mitochondrial Medicine at Children's Hospital of Philadelphia and its Director, Marni Falk, MD. With Frontier Program designation and funding from Children’s Hospital of Philadelphia, the Mitochondrial Medicine, established in 2006, will push the field forward in several complementary domains.
First, it will improve communication between the wide range of clinicians who provide care for patients with a mitochondrial disorder. Next, researchers will find new ways to detect and diagnose these complex conditions. Finally, they will develop and test new treatments that meaningfully improve the health and lives of patients with mitochondrial disease.
Read the full article to learn more about the frontier designation and what it means for the future of patients with mitochondrial disease.